These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27503849)

  • 1. Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart Failure.
    Maeder MT; Zurek M; Rickli H; Tobler D; Kiencke S; Suter T; Yoon SI; Julius B; Pfisterer ME; Brunner-La Rocca HP;
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27503849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential prognostic impact of resting heart rate in older compared with younger patients with chronic heart failure--insights from TIME-CHF.
    Zurek M; Maeder MT; Rickli H; Muzzarelli S; Sanders-van Wijk S; Abbühl H; Handschin R; Jeker U; Pfisterer M; Brunner-la Rocca HP;
    J Card Fail; 2015 Apr; 21(4):347-54. PubMed ID: 25576682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.
    Conraads VM; Spruit MA; Braunschweig F; Cowie MR; Tavazzi L; Borggrefe M; Hill MR; Jacobs S; Gerritse B; van Veldhuisen DJ
    Circ Heart Fail; 2014 Mar; 7(2):279-87. PubMed ID: 24519908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
    Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
    J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure.
    Habal MV; Liu PP; Austin PC; Ross HJ; Newton GE; Wang X; Tu JV; Lee DS
    Circ Heart Fail; 2014 Jan; 7(1):12-20. PubMed ID: 24297690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve).
    Böhm M; Perez AC; Jhund PS; Reil JC; Komajda M; Zile MR; McKelvie RS; Anand IS; Massie BM; Carson PE; McMurray JJ;
    Eur J Heart Fail; 2014 Jul; 16(7):778-87. PubMed ID: 24864045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program.
    Vazir A; Claggett B; Jhund P; Castagno D; Skali H; Yusuf S; Swedberg K; Granger CB; McMurray JJ; Pfeffer MA; Solomon SD
    Eur Heart J; 2015 Mar; 36(11):669-75. PubMed ID: 25368202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
    Kitai T; Grodin JL; Mentz RJ; Hernandez AF; Butler J; Metra M; McMurray JJ; Armstrong PW; Starling RC; O'Connor CM; Swedberg K; Tang WH
    Eur J Heart Fail; 2017 Feb; 19(2):241-249. PubMed ID: 27634557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.
    Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM
    JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a heart rate paradox in acute heart failure?
    Lourenço P; Ribeiro A; Cunha FM; Pintalhão M; Marques P; Cunha F; Silva S; Bettencourt P
    Int J Cardiol; 2016 Jan; 203():409-14. PubMed ID: 26544063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Rate and its Variability Assessed by Spectral Analysis in Elderly Subjects with Orthostatic Hypotension: A Case-Control Study.
    Silva RMFLD; Miranda CES; Barbosa MT; Bicalho MAC
    Arq Bras Cardiol; 2018 Apr; 110(4):303-311. PubMed ID: 29561965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
    Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of ECG abnormalities for mortality risk in acute heart failure: insight from the Sub-Saharan Africa Survey of Heart Failure (THESUS-HF).
    Dzudie A; Milo O; Edwards C; Cotter G; Davison BA; Damasceno A; Mayosi BM; Mondo C; Ogah O; Ojji D; Sani MU; Sliwa K
    J Card Fail; 2014 Jan; 20(1):45-52. PubMed ID: 24269854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Dietary Sodium Restriction on Heart Failure Outcomes.
    Doukky R; Avery E; Mangla A; Collado FM; Ibrahim Z; Poulin MF; Richardson D; Powell LH
    JACC Heart Fail; 2016 Jan; 4(1):24-35. PubMed ID: 26738949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial.
    Huijts M; van Oostenbrugge RJ; Duits A; Burkard T; Muzzarelli S; Maeder MT; Schindler R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Jun; 15(6):699-707. PubMed ID: 23384944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.